Chargement en cours...
National Quality Assessment Evaluating Spironolactone Use During Hospitalization for Acute Myocardial Infarction (AMI) in China: China Patient-centered Evaluation Assessment of Cardiac Events (PEACE)-Retrospective AMI Study, 2001, 2006, and 2011
BACKGROUND: Spironolactone, the only aldosterone antagonist available in China, improves outcomes in acute myocardial infarction (AMI) among patients with systolic dysfunction and either diabetes or heart failure (HF). However, national practice patterns in the use of spironolactone in China are unk...
Enregistré dans:
| Publié dans: | J Am Heart Assoc |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599529/ https://ncbi.nlm.nih.gov/pubmed/26071031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.114.001718 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|